Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
12.00
+0.18 (1.48%)
Aug 6, 2026, 5:52 AM EDT - Market open

Vicore Pharma Holding AB Revenue

Vicore Pharma Holding AB had revenue of 602.00K SEK in the quarter ending March 31, 2026, a decrease of -32.51%. This brings the company's revenue in the last twelve months to 3.53M, down -41.17% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.

Revenue (ttm)
3.53M SEK
Revenue Growth
-41.17%
P/S Ratio
895.15
Revenue / Employee
88,175 SEK
Employees
40
Market Cap
331.75M USD

Revenue Chart

Chart
* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.82M-105.53M-96.51%
Dec 31, 2024109.35M--
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 2018508.00K-424.00K-45.49%
Dec 31, 2017932.00K80.00K9.39%
Dec 31, 2016852.00K12.00K1.43%
Dec 31, 2015840.00K-11.00K-1.29%
Dec 31, 2014851.00K131.00K18.19%
Dec 31, 2013720.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals217.78M
Clinuvel Pharmaceuticals64.24M
Fennec Pharmaceuticals51.00M
Zentalis Pharmaceuticals26.87M
Opus Genetics11.98M
Fate Therapeutics6.32M
Compass Therapeutics850.00K
Lyell Immunopharma31.00K
Revenue Rankings

VCRE News

More News